So-called 'human challenge' trials are expected to begin in January at a quarantine facility in London, report says.... Sep 25
So-called "challenge trials" are expected to begin in January at a quarantine facility in London, the report said.... Sep 24
The approval was given after its clinical trials on COVID-19 patients in India was found satisfactory by the expert committee comprising pulmonologists... Jul 15
Biocon and Mylan’s proposed biosimilar bevacizumab is expected to be the third biosimilar from the partnered portfolio for the cancer patients in the U.... Mar 12
CEO of BIOCON confirmed "We are extremely pleased with the U.S. court ruling in favour of our Insulin Glargine device as this takes us ... Mar 12
True North to invest 536.24 crores in Biocon for 2.44% minority stake... Jan 07
The leading private equity fund had earlier invested both in Biocon and its arm Syngene ... Jan 06